Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Industry-Supported Event

Innovation Theater
General Topic: Innovation Theater

IT26S5: A Product Theater for Zepbound® (tirzepatide) injection including an Affordability Solution for Taltz® (ixekizumab) Patients

Sunday, October 26, 2025
3:30 PM - 4:15 PM Central Time
Location: Innovation Theater B
CE: 0.00

Non-CME In Person

    Industry Presenter(s)

  • Philip Mease, MD

    Rheumatologist, Director of Rheumatology Research, Clinical Professor Director of Rheumatology Research Swedish Medical Center/Providence-St Joseph Health
    Swedish Medical Center/Providence St. Joseph Health
    Seattle, Washington, United States

    Disclosure information not submitted.

  • SM

    Samy Metyas, MD

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits through ACR.
This session will not be recorded for on-demand.

Join us for this Lilly event!

Please see Full Prescribing Information for Zepbound including Boxed Warning and Medication Guide at the product theater or on www.zepbound.lilly.com. Developed and offered by Lilly. Not an official program of the ACR.